ALDA Receives New DIN for T36(R) Antiseptic Hand Sanitizer Wipes

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Jan. 19, 2009) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) ("the Company" or "ALDA") announces that a new DIN has been issued by Health Canada for T36(R) Antiseptic Hand Sanitizer Wipes (02321947). This new product complements ALDA's previously approved T36(R) Antiseptic Hand Sanitizer Gel (DIN 02314320) and T36(R) Antiseptic Hand Sanitizer Liquid (DIN 02321424) and allows the formulation to be manufactured and sold as wipes.

Compared to typical alcohol-based hand sanitizers, ALDA's T36(R) Antiseptic Hand Sanitizer is a unique formula with two active ingredients that provide faster action against a broader range of infectious organisms and offer a long-lasting residual effect.

Dr. Terrance Owen, President & CEO states, "With three DIN's for the T36(R) Antiseptic Hand Sanitizer and one for the T36(R) Disinfex Disinfectant Cleaner (DIN 02314134), we now have four approved consumer products. Being able to offer these products separately or bundled together in various combinations provides a great deal of flexibility to our customers."

About ALDA Pharmaceuticals

ALDA is focused on the development of infection-control therapeutics derived from its patented T36(R) technology. The company trades on the TSX Venture Exchange under the symbol APH.

Terrance G. Owen, Ph.D., MBA, President & CEO

ALDA Pharmaceuticals Corp.

FOR FURTHER INFORMATION PLEASE CONTACT:

ALDA Pharmaceuticals Corp.

Peter Chen

Distribution & Sales Contact

(604) 521-8300 Ext. 3

(604) 521-8322 (FAX)

Email: peter_chen@aldacorp.com

or

ALDA Pharmaceuticals Corp.

Scott Young

Investor Relations Contact

(604) 288-7222

Email: syoung@freeformcom.com

Website: www.aldacorp.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.